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Objective: The development of right ventricular dysfunction has become a common problem after surgical repair
of complex congenital heart disease. A recent study reported that tissue-engineered skeletal myoblast sheet
transplantation improves left ventricular function in patients with dilated and ischemic cardiomyopathy. There-
fore myoblast sheet transplantation might also improve ventricular performance in a rat model of a pressure-over-
loaded right ventricle.
Methods: Seven-week-old male Lewis rats underwent pulmonary artery banding. Four weeks after pulmonary
artery banding, myoblast sheet transplantation to the right ventricle was performed in the myoblast sheet trans-
plantation group (n ¼ 20), whereas a sham operation was performed in the sham group (n ¼ 20).
Results: Four weeks after performing the procedure, a hemodynamic assessment with a pressure–volume loop
showed a compensatory increase in systolic function in both groups. However, only the myoblast sheet transplan-
tation group showed a significant improvement in the diastolic function: end-diastolic pressure (sham vs myoblast
sheet transplantation, 10.3  3.1 vs 5.0  3.7 mm Hg; P<.001), time constant of isovolumic relaxation (11.1 
2.5 vs 7.6  1.2 ms, P< .001), and end-diastolic pressure–volume relationship (16.1  4.5 vs 7.6  2.4/mL,
P< .005). The right ventricular weight and cell size similarly increased in both groups. A histologic assessment
demonstrated significantly suppressed ventricular fibrosis and increased capillary density in the myoblast sheet
transplantation group in comparison with those in the sham group. Reverse transcription–polymerase chain re-
action demonstrated an increased myocardial gene expression of hepatocyte growth factor and vascular endothe-
lial growth factor in the myoblast sheet transplantation group but not in the sham group.
Conclusions: Skeletal myoblast sheet transplantation improved the diastolic dysfunction and suppressed ventric-
ular fibrosis with increased capillary density in a rat model of a pressure-overloaded right ventricle. This method
might become a novel strategy for the myocardial regeneration of right ventricular failure in patients with
congenital heart disease.Because of recent developments in diagnostic methods, the
establishment of new surgical techniques, and improve-
ments in perioperative management, patients with complex
congenital heart disease (CHD) are today often able to sur-
vive to adulthood. However, even after a successful repair,
right ventricular (RV) overload remains in some patients,
in whom it impairs RV function and influences long-term
mortality and morbidity.1-3 Chronic pressure overload is
one of the major risk factors of RV dysfunction. In this
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function is initially preserved, whereas diastolic function
gradually deteriorates.4,5 Prolonged exposure to excessive
pressure overload results in irreversible RV failure. Clini-
cally, the relationship between progressive fibrosis and RV
function must be addressed.6-8
Recently, cardiac regeneration therapy has provided a new
treatment for end-stage heart failure, and skeletal myoblasts
are currently thought to be a potential cell source.9-11 We
developed a novel cell delivery system using temperature-
responsive culture dishes,12 and tissue-engineered cell sheets
have been created without any scaffold, which maintains cell–
cell interaction and extracellular matrix while avoiding any
inflammatory reaction, and with improved cell survival.13
Skeletal myoblast sheet transplantation (MST) has been
shown to improve left ventricular (LV) contractility in several
animal models of LV failure.14-16 Otherwise, it is unclear
whether MST can also affect the right ventricle, especially
pressure-induced RV dysfunction. Hence this study assessed
whether MST could improve RV function in rats after damage
caused by pressure overload.rgery c August 2009
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BW ¼ body weight
CFR ¼ coronary flow reserve
EDPVR ¼ end-diastolic pressure–volume
relationship
Ees ¼ end-systolic elastance
ESPVR ¼ end-systolic pressure–volume
relationship
GAPDH ¼ glyceraldehyde-3-phosphate
dehydrogenase
HGF ¼ hepatocyte growth factor
IVS ¼ intraventricular septum
LV ¼ left ventricular
MS ¼ myoblast cell sheet
MST ¼ myoblast sheet transplantation
PA ¼ pulmonary artery
PAB ¼ pulmonary artery banding
PRSW ¼ preload recruitable stroke work
RT-PCR ¼ reverse transcription–polymerase
chain reaction
RV ¼ right ventricular
SW ¼ stroke work
VEGF ¼ vascular endothelial growth factor
MATERIALS AND METHODS
Animal Care
All experimental procedures and protocols used in this investigation
were reviewed and approved by the institutional animal care and use com-
mittee and are in accordance with the National Institutes of Health ‘‘Guide
for the care and use of laboratory animals’’ (National Institutes of Health
publication no. 85-23, revised 1996).
Creation of Chronic RV Pressure Overload
A rat model of pulmonary artery banding (PAB) was established to create
chronic RV pressure overload. Seven-week-old male Lewis rats (180–210 g)
were anesthetized with an intraperitoneal injection of ketamine hydrochlo-
ride (50 mg/kg) and xylazine (5 mg/kg) and ventilated by using a volume-
controlled respirator (2 mL, 60 cycles/min) with room air. A left thoracotomy
was performed at the fourth intracostal space, and the main pulmonary artery
(PA) was carefully exposed. As previously reported,17 a 19-gauge injection
needle (outer diameter, 1.1 mm) was placed alongside the PA, and a 3-0 poly-
ester suture was tied tightly around the PA and the needle. Next, the needle
was rapidly removed, and then a fixed diameter was set for the PA. There-
after, the thorax was closed in layers, and the ventilator setting was changed
(90 cycles/min) for half an hour to reduce the respiratory load.
Skeletal Myoblast Sheet Preparation
Creation of myoblast cell sheets (MSs) with temperature-responsive cul-
ture dishes (UpCell; Cellseed, Tokyo, Japan) was done according to previ-
ous reports.14-16 Briefly, skeletal muscle was harvested from the hind legs of
4-week-old syngeneic rats. The purified myoblasts were incubated on
35-mm UpCell dishes at 37C, with the cell numbers adjusted to 3 3 106
per dish. After 12 to 18 hours, the dishes were moved to a refrigerator set
at 20C and left there for 30 minutes. During that time, the MSs detached
spontaneously from the surfaces. Each sheet measured from 10 to 15 mm
in diameter.The Journal of Thoracic andSkeletal MST
Four weeks after PAB, a second left thoracotomy was performed at the
fifth intracostal space after achievement of general anesthesia. After opening
the pericardium, the RV anterior wall was exposed. Two MSs were grafted
onto each anterior wall of the right ventricle in the MST group (n ¼ 20), or
a sham operation was performed in the sham group (n ¼ 20). The pericar-
dium was closed linearly before the thorax was closed to prevent the dislo-
cation of MSs. In addition, age-matched rats that did not undergo surgical
intervention were also prepared as a control group (n ¼ 20).
Hemodynamic Study and Data Analysis
Four weeks after the MST or sham operation, 10 rats in each group were
anesthetized and ventilated again and were set on the blanket warmer to
maintain body temperature. A median sternotomy was performed, and the
pericardium was opened carefully to minimize hemorrhaging. A silk thread
was placed under the inferior vena cava just above the diaphragm to change
the RV preload. After purse-string sutures were attached with 7-0 polypro-
pylene, the conductance catheter (Unique Medical Co, Tokyo, Japan) was
inserted through the RV apex toward the pulmonary valve along the longi-
tudinal axis of the RV cavity and then fixed. A Miller 1.4F pressure-tip cath-
eter (SPR-719; Millar Instruments, Houston, Tex) was also inserted from
the RV anterior wall and fixed. For better volume measurement, a 1-mm
curve was added to the original standard straight conductance catheter to
fit the complex RV geometry. The position of the conductance catheter
was determined by observing the pressure and segmental volume signals
with the appropriate phase relationships. The conductance system and the
pressure transducer controller (Integral 3 [VPR-1002], Unique Medical
Co) were set as previously reported.18 Pressure–volume loops and intracar-
diac electrocardiograms were monitored online, and the conductance, pres-
sure, and intracardiac electrocardiographic signals were analyzed with
Integral 3 software (Unique Medical Co).18
Under stable hemodynamic conditions, the baseline indices were ini-
tially measured, and then the pressure–volume loop was drawn during infe-
rior vena caval occlusion and analyzed (Figure 1). Finally, the conductivity
of the sampled blood was measured with a small (0.1 mm) cuvette, and the
parallel conductance volume was measured with the hypertonic saline dilu-
tion method to obtain the absolute volumes.19
The following indices were calculated as the baseline RV function: heart
rate, end-systolic pressure, end-diastolic pressure, dP/dtmax, dP/dtmin, and
the time constant of isovolumic relaxation (t). The following relationships
were determined by means of pressure–volume loop analysis as load-inde-
pendent measures of RV function: end-systolic pressure–volume relation-
ship (ESPVR), end-diastolic pressure–volume relationship (EDPVR), and
preload recruitable stroke work (PRSW).
The ESPVR is linear, and it can be characterized by a slope (end-
systolic elastance [Ees]) and a volume axis intercept (Vo), so that
Pes ¼ EesðVesVoÞ, where Pes and Ves are the end-systolic pressure
and volume, respectively.20
In contrast, the EDPVR is intrinsically thought to be nonlinear. The
relationship between the end-diastolic pressure (Ped) and volume (Ved)
can be fitted to the monoexponential, so that Ped ¼ PoþbeKvVed , where
Po is the pressure asymptote (generally close to 0 mm Hg), b is a constant,
and Kv is the variable represented as a ventricular stiffness property.21
The relationship between ventricular stroke work (SW) and end-diastolic
volume (Ved) is represented as PRSW. PRSW is thought to be a suitable
parameter of the contractile state and fitted to the following equation:
SW ¼ KðVedVoÞ, where K is a constant as a potential measure of intrinsic
myocardial performance independent of loading, geometry, and heart rate.22
Histopathologic Analysis
The other 10 rats in each group were killed 4 weeks after the sham or
MST operation for histologic analysis, reverse transcription–polymerase
chain reaction (RT-PCR), and blood sampling. The hearts were quickly
removed, and the ventricles were dissected free of atrial tissue and largeCardiovascular Surgery c Volume 138, Number 2 461
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Evolving Technology/Basic Science Hoashi et alFIGURE 1. Representative pressure–volume loops of the control (A), sham (B), and myoblast sheet transplantation (MST; C) groups under different loading
conditions. The slope of the end-systolic pressure–volume relationship is displayed as a black straight line. The correlation of the end-diastolic pressure–
volume relationship is displayed as a green monoexponential curve. RVP, Right ventricular pressure; RV, right ventricle.blood vessels. The right ventricle was carefully separated from the left
ventricle and intraventricular septum (IVS). The fresh ventricular tissues
were immediately blotted dry and weighted separately to determine the de-
gree of RV hypertrophy based on 2 parameters: RV wall weight/body
weight (RV/BW) and RV wall weight/LV and IVS wall weight (RV/
LVþIVS).
Tissue specimens were obtained from the endocardium, the midwall,
and the epicardium of the RV anterior wall in cross-sections, cut into
5-mm-thick sections, and stained with hematoxylin and eosin for morpho-
logic analysis, including measurement of RV wall thickness, periodic acid–
Schiff staining to measure the short-axis length of the RV myocardial cell,
Factor VIII–related antigen staining (Dako EPOS anti-human Von
Willebrand factor/HRP; Dako Cytomation, Glostrup, Denmark) to quantify
capillary vascular density, and Masson trichrome staining for determina-
tion of the amount of interstitial and myocardial fibrosis. The percentage
of interstitial and myocardial fibrosis were assessed by a computer-based
method23,24 with the use of a software filter (Mac Scope Software;
MITANI Corp, Tokyo, Japan), which can recognize the distinct color
shades. The number of pixels of the blue-stained collagen area was calcu-
lated, then divided by the total number of pixels in a field. Each 3 fields of
the endocardial, epicardial, and mid layers of the RV wall per slide were
analyzed and then averaged.
RT-PCR
Total RNA was isolated from the stored specimens by using the RNeasy
Mini Kit (Qiagen, Hilden, Germany) and reverse transcribed with Omni-
script Reverse Transcriptase (Qiagen). RT-PCR was performed with the
ABI PRISM 7700 (Applied Biosystems, Foster City, Calif). Measurement
of the mRNA expression of hepatocyte growth factor (HGF) and vascular
endothelial growth factor (VEGF) was performed in triplicate. The results
are expressed after normalization for glyceraldehyde-3-phosphate dehydro-
genase (GAPDH).
Statistical Analysis
All data were expressed as the mean  SEM and range. Student’s
unpaired t test or analysis of variance for parametric values was used to com-
pare group means.
RESULTS
Pressure Overload and Hypertrophy of the Right
Ventricle After PAB
After PAB, a weight analysis showed the heart weight/BW,
RV/BW, and RV/(LVþIVS) weight ratios in the sham and462 The Journal of Thoracic and Cardiovascular SuMST groups to be similar and significantly higher than in
the control group (Table 1). Both the sham and MST groups
showed a significantly increased end-systolic pressure and
dP/dtmax than seen in the control group (Table 2).
Hemodynamic Effects of MST
The baseline indices revealed that end-diastolic pressure
and t values were significantly increased only in the sham
group in comparison with those in the control group but
not in the MST group (Table 2). Typical examples of the
pressure–volume loop in each group are presented in
Figure 1. The pressure–volume loop analysis revealed that
the ESPVR and PRSW values significantly increased both
in the sham and MST groups. However, the EDPVR value
significantly increased only in the sham group (control vs
sham vs MST groups: 8.6  2.9 vs 16.1  4.5 vs 7.6 
2.4/mL; P< .05 in the control and MST groups vs the
sham group; Table 2).
Histologic Effects of MST
Whole heart findings showed the RV wall thickened, the
cavity enlarged, and the IVS shifted toward the left side in
the sham and MST groups (Figure 2, A). In the MST group
transplanted MSs were observed as an elastic thin layer on
the epicardium (Figure 2, B). The RV wall thickness and
myocardial cell size in the sham and MST groups were sim-
ilar and significantly higher than in the control group
(Figure 2, C–E).
TABLE 1. Weight analysis at the fourth week after the operation
Group Control Sham MST
HW/BW (mg/g) 2.62  0.09 3.53  0.50* 4.03  0.59*
RV/BW (mg/g) 0.54  0.15 1.62  0.42* 1.65  0.32*
RV/(IVSþLV) 0.27  0.08 0.69  0.11* 0.69  0.09*
MST, Myoblast sheet transplantation; HW, heart weight; BW, body weight; RV, right
ventricle; IVS, interventricular septum; LV, left ventricle. *P< .05 versus the control
group.rgery c August 2009
Hoashi et al Evolving Technology/Basic ScienceTABLE 2. Hemodynamic indices at the fourth week after the operation
Group Control Sham MST
Basic hemodynamic indices
HR (beats/min) 280  72 233  34 249  65
ESP (mm Hg) 22.8  2.9 82.3  11.8* 78.7  13.2*
EDP (mm Hg) 2.4  1.4 10.3  3.1*y 5.0  3.7
dP/dtmax (mm Hg/s) 1301  206 3197  597* 3352  1332*
dP/dtmin (mm Hg/s) 997  210 2466  582* 2682  828*
t (ms) 7.9  2.7 11.1  2.5*y 7.6  1.2
Load-independent parameters analyzed by PV loop
ESPVR (mm Hg/mL) 538  196 857  305* 967  201*
EDPVR (/mL) 8.6  2.9 16.1  4.5*y 7.6  2.4
PRSW (mm Hg) 17.0  4.1 40.2  19.6* 40.8  13.6*
PRSW/RV (mm Hg/kg) 88.3  23.9 71.5  31.3 73.6  28.8
MST, Myoblast sheet transplantation; HR, heart rate; ESP, end-systolic pressure; EDP, end-diastolic pressure; PV, pressure–volume; ESPVR, end-systolic pressure–volume
relationship; EDPVR, end-diastolic pressure–volume relationship; PRSW, preload-recruitable stroke work; RV, right ventricular weight. *P< .05 versus the control group. yP
< .05 versus the MST group.Factor VIII stain showed that myocardial capillary vascu-
lar density showed no significant difference at the mid layer
and endocardial layer (Figure 3, B and C), but it was signif-
icantly higher in the MST group than in the other 2 groups at
the epicardial layer (Figure 3, A). Hence, total capillary den-
sity in the MST group was significantly higher than in theThe Journal of Thoracic andother 2 groups (control vs sham vs MST groups: 262  98
vs 271  289 vs 823  708; P<0.05 in the control and
sham groups vs the MST group; Figure 3, D).
Periodic acid–Schiff staining demonstrated significant
interstitial fibrosis of the right ventricle in both the sham
and MST groups, but the percentage of fibrosis in theE
T
/B
SFIGURE 2. Macroscopic photographs of hematoxylin and eosin–stained sections showing right ventricular (RV) wall thickening, cavity enlarging, and the
intraventricular septum shifting towered the left side in the sham and myoblast sheet transplantation (MST) groups (A and D). Photomicrographs (403, scale
bar¼ 200 mm) of hematoxylin and eosin–stained sections showed a fibrous organized thin layer on the epicardium in the myoblast sheet transplantation group
(B). Photomicrographs (4003, scale bar ¼ 20 mm) of periodic acid–Schiff–stained sections showed significantly hypertrophied ventricular myocytes in the
sham and myoblast sheet transplantation groups (C and E). *P< .05 (n ¼ 10).Cardiovascular Surgery c Volume 138, Number 2 463
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Evolving Technology/Basic Science Hoashi et alFIGURE 3. Representative photomicrographs (1003, scale bar ¼ 100 mm) of Factor VIII–stained epicardial layer (A), mid layer (B), and endocardial layer
(C). Neovascularization occurred at the epicardial layer in the myoblast sheet transplantation (MST) group (D). *P< .05 (n ¼ 10).MST group was significantly less than that in the sham
group (control vs sham vs MST groups: 4.8%  1.1% vs
24.5%  10.0% vs 19.0%  5.1%; P < .05 between
each 2 groups; Figure 4, A and E). Aggregated endomyocar-
dial fibrosis was detected only in the sham group (endomyo-
cardial percentage of fibrosis, control vs sham vs MST
groups: 5.7%  0.1% vs 31.5%  8.4% vs 18.6% 
5.9%; P< .01 in the control and MST groups vs the sham
group; Figure 4, B–D and F).
RT-PCR
The expression of HGF and VEGF mRNA in the MST
group was significantly higher than in the sham group (con-
trol vs sham vs MST groups: HGF, 0.00009  0.00008 vs
0.00041  0.00030 vs 0.00073  0.00031/GAPDH [P<
.05 in each group]; VEGF, 0.00242  0.00164 vs 0.00329
 0.00181 vs 0.00512  0.00113/GAPDH [P< .05 in the
control and sham group vs the MST group]; Figure 5).
DISCUSSION
This study demonstrated that skeletal MST improved di-
astolic function in a pressure-overloaded right heart model
in rats by means of PAB. This conclusion is supported by
the following evidence: (1) the diastolic function was signif-
icantly improved based on hemodynamic assessment and
pressure–volume loop analysis; (2) interstitial and endocar-
dial fibrosis was ameliorated, and capillary vascular density
of the epicardial layer was increased; and (3) myocardial464 The Journal of Thoracic and Cardiovascular Sugene expression of HGF and VEGF was significantly in-
creased. MST has been shown to have therapeutic effects
in several models of LV failure.14-16 However, the present
results are the first to show evidence that MST is effective
for the treatment of RV dysfunction resulting from chronic
pressure overload.
Prolonged RV pressure overload promotes unique mor-
phologic, histologic, and functional changes. The mechanical
stimulation of pressure overload extends the myocardium,
which leads to diastolic dysfunction.21 Simultaneously, hy-
pertrophied myocardium upregulates the release of various
chemical mediators,17 which induce further myocardial ex-
pansion, apoptosis, necrosis, and fibrosis, finally resulting
in RV decompensation. Otherwise, ventricular hypertrophy
itself reduces the coronary flow reserve (CFR) and leads to
coronary microcirculatory dysfunction.25 As studies on the
left ventricle show, this phenomenon is detected particularly
in the subendocardium.26 The shortage of CFR induces myo-
cardial cellar mortality and endocardial fibrosis, which accel-
erates ventricular dysfunction. The present and previous data
indicate that transplanted elastic cells initially improved ven-
tricular stiffness14 and preserved CFR in the hypertrophied
myocardium, both of which generate a synergistic effect of
the suppression of myocardial cell death and fibrosis, espe-
cially at the endocardial layer. Although an angiogenetic ef-
fect was observed with the increased myocardial gene
expression of HGF and VEGF, we speculate this does not in-
crease endocardial coronary flow directly because increasedrgery c August 2009
Hoashi et al Evolving Technology/Basic ScienceFIGURE 4. Representative photomicrographs of Masson’s trichrome–stained transmural layer (A; 403, scale bar¼ 200 mm), epicardial layer (B), mid layer
(C), and endocardial layer (D; 2003, scale bar ¼ 50 mm) for evaluation of interstitial (E) and endomyocardial (F) fibrosis. *P< .05 (n ¼ 10).E
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Scapillary density was only seen at epicardial layer. These new
capillaries might increase the blood supply to the transplanted
myoblasts and prolong their survival.13
As several LV studies have previously shown, Lamberts
and colleagues27 revealed the strict relationship between
RV chamber stiffness and the degree of myocardial fibrosis.
In their report they also described that prevention or reduc-
tion of RV fibrosis improved RV diastolic dysfunction.
Although we could not show any individual correlation
between collagen contents and hemodynamic parameters
in regard to diastolic function, these findings strongly
support our results. Therefore we would like to emphasize
that the suppression of fibrosis improved the RV diastolic
function.
The hemodynamic assessment of cardiac performance of
a hypertrophied right ventricle has not been established.
Various attempts have been made; however, it is still
necessary to perform cardiac catheterization to evaluate he-
modynamics, especially regarding diastolic function.28,29
Leeuwenburgh and associates4 showed that RV compliance
deteriorated in a lamb model and described t and EDPVR
values to be useful indicators for diastolic function. Gaynor
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MSTshamcontrolMSTshamcontrol
VEGFHGF
FIGURE 5. RT-PCR for evaluation of neurohormonal factor gene expres-
sion. The results are expressed after normalization for GAPDH. HGF,
Hepatocyte growth factor; VEGF, vascular endothelial growth factor.
*P< .05 (n ¼ 10).
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model of PAB. The current results are consistent with these
reports. Therefore these data appear to be reliable.
On the other hand, the assessment of systolic function still
remains controversial. In this study we showed that ESPVR
(Ees) and PRSW were significantly increased in sham
groups, as previously reported.30 However, Dell’Italia and
Walsh31 pointed out that in the assessment of RV contractil-
ity, the slope of ESPVR (Ees) was different from the slope of
the maximum time-varying elastance, which better reflected
the RV contractility than Ees. In addition to Ees, PRSW is
thought to be an optimal parameter of ventricular contractil-
ity. However, we might have to consider the discrepancy of
the cardiac mass between normal and hypertrophied hearts
because ventricular SW should be assessed as a per-unit car-
diac mass. We tried to calculate the PRSW divided for each
animal’s RV weight, which revealed there was no statistical
significance among the 3 groups (control vs sham vs MST
groups: 88.3  23.9 vs 71.5  31.3 vs 73.6  28.8 mm
Hg/kg, Table 2). Hence it is hard to say that the RV pressure
load induced a further improvement in RV contractility.
We need further investigation to apply this method to
clinical RV failure because we did not ascertain the effect
of MST on RV systolic function. Nevertheless, enormous
fibrosis was seen in the sham group, and systolic function
was still compensated until the timing of hemodynamic eval-
uation. However, previous reports showed that MST had an
excellent effect on LV contractility.14-16 Therefore we ex-
pect that this method might become a novel and potentially
effective treatment strategy for patients with RV failure.
In conclusion, chronic pressure overload to the right ven-
tricle caused hypertrophy and impaired diastolic function in
rats. Skeletal MST attenuated diastolic dysfunction, which
was mainly caused by suppressed interstitial and endocardial
fibrosis. This method might become a novel strategy for the
myocardial regeneration of RV failure in patients with CHD
in the future.
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